General Continuous glucose monitors show strong survival benefits for type 2 diabetes patientsBy Healthcare Propulsion StaffSeptember 28, 20260 People with type 2 diabetes (T2D) on basal insulin, starting continuous glucose monitoring (CGM) had a 44% lower risk of…
General Research makes strong case for broader use of GLP1 drugs to protect heartsBy Healthcare Propulsion StaffSeptember 28, 20260 New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan,…
